{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T20:44:27Z","timestamp":1788813867799,"version":"build-2803163510"},"reference-count":62,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejso.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Surgical Oncology"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.ejso.2025.109689","type":"journal-article","created":{"date-parts":[[2025,2,20]],"date-time":"2025-02-20T08:12:09Z","timestamp":1740039129000},"page":"109689","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["The efficacy and oncological safety of minimally invasive axillary procedures in patients with node-positive breast cancer receiving neoadjuvant chemotherapy: A network meta-regression and trial sequential analysis"],"prefix":"10.1016","volume":"51","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6979-7818","authenticated-orcid":false,"given":"James","family":"Lucocq","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8999-0474","authenticated-orcid":false,"given":"Hassan","family":"Baig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5175-4561","authenticated-orcid":false,"given":"Esther","family":"McNeill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J Michael","family":"Dixon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.ejso.2025.109689_bib12","doi-asserted-by":"crossref","first-page":"218","DOI":"10.21037\/atm-22-4961","article-title":"Oncologic outcomes in breast cancer patients with metastatic nodes and pathological nodal response following neoadjuvant chemotherapy without axillary dissection: a literature review","volume":"11","author":"Lim","year":"2023","journal-title":"Ann Transl Med"},{"issue":"13","key":"10.1016\/j.ejso.2025.109689_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejca.2009.04.029","article-title":"Towards rational axillary treatment in relation to neoadjuvant therapy in breast cancer","volume":"45","author":"Straver","year":"2009","journal-title":"Eur J Cancer"},{"issue":"3","key":"10.1016\/j.ejso.2025.109689_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejso.2015.11.018","article-title":"Sentinel lymph node biopsy after neoadjuvant treatment in breast cancer: work in progress","volume":"42","author":"Rubio","year":"2016","journal-title":"Eur J Surg Oncol"},{"issue":"2","key":"10.1016\/j.ejso.2025.109689_bib4","doi-asserted-by":"crossref","DOI":"10.1097\/01.sla.0000197714.14318.6f","article-title":"Accuracy of physical examination, ultrasonography, and mammography in predicting residual pathologic tumor size in patients treated with neoadjuvant chemotherapy","volume":"243","author":"Chagpar","year":"2006","journal-title":"Ann Surg"},{"issue":"7","key":"10.1016\/j.ejso.2025.109689_bib5","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13071539","article-title":"The evolving role of marked lymph node biopsy (Mlnb) and targeted axillary dissection (tad) after neoadjuvant chemotherapy (nact) for node\u2010positive breast cancer: systematic review and pooled analysis","volume":"13","author":"Swarnkar","year":"2021","journal-title":"Cancers"},{"issue":"9","key":"10.1016\/j.ejso.2025.109689_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejso.2018.05.035","article-title":"Wire localization of clip-marked axillary lymph nodes in breast cancer patients treated with primary systemic therapy","volume":"44","author":"Hartmann","year":"2018","journal-title":"Eur J Surg Oncol"},{"issue":"10","key":"10.1016\/j.ejso.2025.109689_bib7","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2015.64.0094","article-title":"Improved axillary evaluation following neoadjuvant therapy for patientswith node-positive breast cancer using selective evaluation of clipped nodes: implementation of targeted axillary dissection","volume":"34","author":"Caudle","year":"2016","journal-title":"J Clin Oncol"},{"issue":"3","key":"10.1016\/j.ejso.2025.109689_bib8","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2014.55.7827","article-title":"Sentinel node biopsy after neoadjuvant chemotherapy in biopsy-proven node-positive breast cancer: the SN FNAC study","volume":"33","author":"Boileau","year":"2015","journal-title":"J Clin Oncol"},{"issue":"7","key":"10.1016\/j.ejso.2025.109689_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/S1470-2045(13)70166-9","article-title":"Sentinel-lymph-node biopsy in patients with breast cancer before and after neoadjuvant chemotherapy (SENTINA): a prospective, multicentre cohort study","volume":"14","author":"Kuehn","year":"2013","journal-title":"Lancet Oncol"},{"issue":"9_Supplement","key":"10.1016\/j.ejso.2025.109689_bib10","doi-asserted-by":"crossref","DOI":"10.1158\/1538-7445.SABCS14-P2-01-02","volume":"75","author":"Boughey","year":"2015","journal-title":"Cancer Res"},{"issue":"22","key":"10.1016\/j.ejso.2025.109689_bib11","doi-asserted-by":"crossref","DOI":"10.1002\/cam4.4769","article-title":"Diagnostic accuracy of de-escalated surgical procedure in axilla for node-positive breast cancer patients treated with neoadjuvant systemic therapy: a systematic review and meta-analysis","volume":"11","author":"Song","year":"2022","journal-title":"Cancer Med"},{"issue":"5","key":"10.1016\/j.ejso.2025.109689_bib13","doi-asserted-by":"crossref","DOI":"10.1097\/SLA.0000000000004572","article-title":"A prospective, multicenter registry study to evaluate the clinical feasibility of targeted axillary dissection (TAD) in node-positive breast cancer patients","volume":"276","author":"Kuemmel","year":"2022","journal-title":"Ann Surg"},{"issue":"10","key":"10.1016\/j.ejso.2025.109689_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejso.2023.05.013","article-title":"Feasibility and safety of targeted axillary dissection guided by intraoperative ultrasound after neoadjuvant treatment","volume":"49","author":"Siso","year":"2023","journal-title":"Eur J Surg Oncol"},{"issue":"11","key":"10.1016\/j.ejso.2025.109689_bib15","doi-asserted-by":"crossref","DOI":"10.1001\/jamasurg.2022.3907","article-title":"Diagnostic accuracy of radioactive iodine seed placement in the axilla with sentinel lymph node biopsy after neoadjuvant chemotherapy in node-positive breast cancer","volume":"157","author":"Simons","year":"2022","journal-title":"JAMA Surg"},{"key":"10.1016\/j.ejso.2025.109689_bib16","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/6111907","article-title":"Evaluation of axillary lymph node marking with Magseed\u00ae before and after neoadjuvant systemic therapy in breast cancer patients: MAGNET study","volume":"2022","author":"Mart\u00ednez","year":"2022","journal-title":"Breast J"},{"issue":"5","key":"10.1016\/j.ejso.2025.109689_bib17","doi-asserted-by":"crossref","DOI":"10.1245\/s10434-020-09211-0","article-title":"Oncologic safety of sentinel lymph node biopsy alone after neoadjuvant chemotherapy for breast cancer","volume":"28","author":"Wong","year":"2021","journal-title":"Ann Surg Oncol"},{"issue":"4","key":"10.1016\/j.ejso.2025.109689_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejso.2020.10.014","article-title":"Long-term standard sentinel node biopsy after neoadjuvant treatment in breast cancer: a single institution ten-year follow-up","volume":"47","author":"Kahler-Ribeiro-Fontana","year":"2021","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.ejso.2025.109689_bib19","series-title":"R: a language and environment for statistical computing","year":"2019"},{"issue":"3","key":"10.1016\/j.ejso.2025.109689_bib20","doi-asserted-by":"crossref","DOI":"10.2307\/2530245","article-title":"A multiple testing procedure for clinical trials","volume":"35","author":"O'Brien","year":"1979","journal-title":"Biometrics"},{"issue":"14","key":"10.1016\/j.ejso.2025.109689_bib1","doi-asserted-by":"crossref","DOI":"10.1001\/jama.2013.278932","article-title":"Sentinel lymph node surgery after neoadjuvant chemotherapy in patients with node-positive breast cancer: the ACOSOG Z1071 (alliance) clinical trial","volume":"310","author":"Boughey","year":"2013","journal-title":"JAMA"},{"issue":"12","key":"10.1016\/j.ejso.2025.109689_bib34","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1097\/CM9.0000000000003007","article-title":"Targeted axillary dissection after neoadjuvant chemotherapy for highly selective patients with initial cN1 breast cancer: a single-center prospective trial","volume":"137","author":"Chen","year":"2024","journal-title":"Chin Med J (Engl)."},{"issue":"4","key":"10.1016\/j.ejso.2025.109689_bib49","doi-asserted-by":"crossref","DOI":"10.1016\/j.clbc.2016.02.009","article-title":"Sentinel lymph node biopsy after neoadjuvant chemotherapy in patients with an initial diagnosis of cytology-proven lymph node-positive breast cancer","volume":"16","author":"Enokido","year":"2016","journal-title":"Clin Breast Cancer"},{"key":"10.1016\/j.ejso.2025.109689_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.suronc.2019.05.019","article-title":"Validation of the targeted axillary dissection technique in the axillary staging of breast cancer after neoadjuvant therapy: preliminary results","volume":"30","author":"Flores-Funes","year":"2019","journal-title":"Surg Oncol"},{"issue":"6","key":"10.1016\/j.ejso.2025.109689_bib50","doi-asserted-by":"crossref","DOI":"10.1111\/1759-7714.12131","article-title":"Sentinel lymph node biopsy does not apply to all axillary lymph node-positive breast cancer patients after neoadjuvant chemotherapy","volume":"5","author":"Ge","year":"2014","journal-title":"Thorac Cancer"},{"issue":"2","key":"10.1016\/j.ejso.2025.109689_bib35","doi-asserted-by":"crossref","DOI":"10.4048\/jbc.2011.14.2.147","article-title":"Feasibility of sentinel lymph node biopsy in breast cancer patients with initial axillary lymph node metastasis after primary systemic therapy","volume":"14","author":"Kang","year":"2011","journal-title":"J Breast Cancer"},{"issue":"4","key":"10.1016\/j.ejso.2025.109689_bib51","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejso.2014.10.066","article-title":"A prospective feasibility study of sentinel node biopsy by modified Indigocarmine blue dye methods after neoadjuvant chemotherapy for breast cancer","volume":"41","author":"Kida","year":"2015","journal-title":"Eur J Surg Oncol"},{"issue":"1","key":"10.1016\/j.ejso.2025.109689_bib52","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.ejso.2009.10.015","article-title":"Axillary sentinel node biopsy after neoadjuvant chemotherapy","volume":"36","author":"Ozmen","year":"2010","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.ejso.2025.109689_bib53","article-title":"Sentinel lymph node biopsy after neoadjuvant chemotherapy in patients with cytologically proven node-positive breast cancer at diagnosis","volume":"vol. 20","author":"Park","year":"2013"},{"issue":"1","key":"10.1016\/j.ejso.2025.109689_bib54","article-title":"Selective sentinel lymph node biopsy after neoadjuvant chemotherapy in breast cancer: results of the GEICAM 2005-07 study","volume":"93","author":"Pi\u00f1ero-Madrona","year":"2015","journal-title":"Cirug\u00eda Espa\u00f1ola"},{"issue":"7","key":"10.1016\/j.ejso.2025.109689_bib55","doi-asserted-by":"crossref","DOI":"10.1002\/cncr.22540","article-title":"Feasibility and accuracy of sentinel lymph node biopsy after preoperative chemotherapy in breast cancer patients with documented axillary metastases","volume":"109","author":"Shen","year":"2007","journal-title":"Cancer"},{"issue":"6","key":"10.1016\/j.ejso.2025.109689_bib56","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.clbc.2013.08.014","article-title":"Sentinel node biopsy after neoadjuvant chemotherapy in cytologically proven node-positive breast cancer","volume":"13","author":"Yagata","year":"2013","journal-title":"Clin Breast Cancer"},{"issue":"1","key":"10.1016\/j.ejso.2025.109689_bib32","doi-asserted-by":"crossref","DOI":"10.1186\/s12957-023-03120-8","article-title":"Carbon nanoparticles localized clipped node dissection combined with sentinel lymph node biopsy with indocyanine green and methylene blue after neoadjuvant therapy in node positive breast cancer in China: initial results of a prospective study","volume":"21","author":"Yang","year":"2023","journal-title":"World J Surg Oncol"},{"issue":"1","key":"10.1016\/j.ejso.2025.109689_bib57","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/s10549-017-4164-1","article-title":"Swedish prospective multicenter trial evaluating sentinel lymph node biopsy after neoadjuvant systemic therapy in clinically node-positive breast cancer","volume":"163","author":"Zetterlund","year":"2017","journal-title":"Breast Cancer Res Treat"},{"issue":"2","key":"10.1016\/j.ejso.2025.109689_bib29","doi-asserted-by":"crossref","DOI":"10.1097\/SLA.0000000000000558","article-title":"Marking axillary lymph nodes with radioactive iodine seeds for axillary staging after neoadjuvant systemic treatment in breast cancer patients the mari procedure","volume":"261","author":"Donker","year":"2015","journal-title":"Ann Surg"},{"issue":"9","key":"10.1016\/j.ejso.2025.109689_bib58","doi-asserted-by":"crossref","DOI":"10.1002\/bjs.10555","article-title":"Combined PET\u2013CT and axillary lymph node marking with radioactive iodine seeds (MARI procedure) for tailored axillary treatment in node-positive breast cancer after neoadjuvant therapy","volume":"104","author":"Koolen","year":"2017","journal-title":"Br J Surg"},{"issue":"8","key":"10.1016\/j.ejso.2025.109689_bib59","doi-asserted-by":"crossref","DOI":"10.1002\/bjs.7073","article-title":"Marking the axilla with radioactive iodine seeds (MARI procedure) may reduce the need for axillary dissection after neoadjuvant chemotherapy for breast cancer","volume":"97","author":"Straver","year":"2010","journal-title":"Br J Surg"},{"issue":"7","key":"10.1016\/j.ejso.2025.109689_bib60","article-title":"Clinical feasibility and oncological safety of non-radioactive targeted axillary dissection after neoadjuvant chemotherapy in biopsy-proven node-positive breast cancer: a prospective diagnostic and prognostic study","volume":"109","author":"Wu","year":"2023","journal-title":"Int J Surg"},{"issue":"3","key":"10.1016\/j.ejso.2025.109689_bib22","doi-asserted-by":"crossref","DOI":"10.4143\/crt.2017.210","article-title":"Feasibility of charcoal tattooing of cytology-proven metastatic axillary lymph node at diagnosis and sentinel lymph node biopsy after neoadjuvant chemotherapy in breast cancer patients","volume":"50","author":"Park","year":"2018","journal-title":"Cancer Res Treat"},{"issue":"3","key":"10.1016\/j.ejso.2025.109689_bib23","doi-asserted-by":"crossref","DOI":"10.1245\/s10434-017-6270-z","article-title":"Intraoperative ultrasound-guided excision of axillary clip in patients with node-positive breast cancer treated with neoadjuvant therapy (ilina trial): a new tool to guide the excision of the clipped node after neoadjuvant treatment","volume":"25","author":"Siso","year":"2018","journal-title":"Ann Surg Oncol"},{"issue":"1","key":"10.1016\/j.ejso.2025.109689_bib24","doi-asserted-by":"crossref","DOI":"10.1186\/s13058-024-01807-8","article-title":"Outcomes of sentinel node biopsy according to MRI response in an association with the subtypes in cN1\u20133 breast cancer after neoadjuvant systemic therapy, multicenter cohort study","volume":"26","author":"Bae","year":"2024","journal-title":"Breast Cancer Res"},{"issue":"7","key":"10.1016\/j.ejso.2025.109689_bib25","doi-asserted-by":"crossref","first-page":"4381","DOI":"10.1245\/s10434-024-15292-y","article-title":"Oncologic outcomes for different axillary staging techniques in patients with nodal-positive breast cancer undergoing neoadjuvant systematic treatment: a cancer registry study","volume":"31","author":"Pfob","year":"2024","journal-title":"Ann Surg Oncol"},{"issue":"1","key":"10.1016\/j.ejso.2025.109689_bib47","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-88442-x","article-title":"Sentinel node biopsy alone for breast cancer patients with residual nodal disease after neoadjuvant chemotherapy","volume":"11","author":"Chun","year":"2021","journal-title":"Sci Rep"},{"issue":"3","key":"10.1016\/j.ejso.2025.109689_bib46","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejso.2022.11.099","article-title":"Omission of axillary lymph node dissection in patients with ypN+ breast cancer after neoadjuvant chemotherapy: a retrospective multicenter study (KROG 21-06)","volume":"49","author":"Park","year":"2023","journal-title":"Eur J Surg Oncol"},{"issue":"2","key":"10.1016\/j.ejso.2025.109689_bib61","article-title":"Regional recurrence rates with or without complete axillary dissection for breast cancer patients with node-positive disease on sentinel lymph node biopsy after neoadjuvant chemotherapy","volume":"5","author":"Ling","year":"2020","journal-title":"Adv Radiat Oncol"},{"issue":"2","key":"10.1016\/j.ejso.2025.109689_bib62","doi-asserted-by":"crossref","DOI":"10.1007\/s10549-023-07062-3","article-title":"Impact of axillary surgery on outcome of clinically node positive breast cancer treated with neoadjuvant chemotherapy","volume":"202","author":"Dux","year":"2023","journal-title":"Breast Cancer Res Treat"},{"issue":"8","key":"10.1016\/j.ejso.2025.109689_bib45","doi-asserted-by":"crossref","DOI":"10.1001\/jamasurg.2023.1772","article-title":"Safety of targeted axillary dissection after neoadjuvant therapy in patients with node-positive breast cancer","volume":"158","author":"Kuemmel","year":"2023","journal-title":"JAMA Surg"},{"issue":"3","key":"10.1016\/j.ejso.2025.109689_bib26","doi-asserted-by":"crossref","DOI":"10.1097\/SLA.0000000000003075","article-title":"Diagnostic accuracy of different surgical procedures for axillary staging after neoadjuvant systemic therapy in node-positive breast cancer: a systematic review and meta-analysis","volume":"269","author":"Simons","year":"2019","journal-title":"Ann Surg"},{"issue":"3","key":"10.1016\/j.ejso.2025.109689_bib27","doi-asserted-by":"crossref","DOI":"10.1007\/s10434-001-0192-4","article-title":"Sentinel lymph node biopsy for melanoma: how many radioactive nodes should be removed?","volume":"8","author":"McMasters","year":"2001","journal-title":"Ann Surg Oncol"},{"issue":"5","key":"10.1016\/j.ejso.2025.109689_bib28","article-title":"Outcomes of sentinel node biopsy for women with breast cancer after neoadjuvant therapy: systematic review and meta-analysis of real-world data","volume":"29","author":"Lin","year":"2022","journal-title":"Ann Surg Oncol"},{"issue":"10","key":"10.1016\/j.ejso.2025.109689_bib30","doi-asserted-by":"crossref","DOI":"10.1245\/s10434-018-6575-6","article-title":"Improved false-negative rates with intraoperative identification of clipped nodes in patients undergoing sentinel lymph node biopsy after neoadjuvant chemotherapy","volume":"25","author":"Cab\u0131o\u011flu","year":"2018","journal-title":"Ann Surg Oncol"},{"issue":"1","key":"10.1016\/j.ejso.2025.109689_bib31","doi-asserted-by":"crossref","DOI":"10.4048\/jbc.2023.26.e6","article-title":"Feasibility of ultrasound-guided localization for clipped metastatic axillary lymph nodes after neoadjuvant chemotherapy in breast cancer patients: a pilot study","volume":"26","author":"Kim","year":"2023","journal-title":"J Breast Cancer"},{"issue":"14","key":"10.1016\/j.ejso.2025.109689_bib33","doi-asserted-by":"crossref","DOI":"10.1001\/jama.2013.278932","article-title":"Sentinel lymph node surgery after neoadjuvant chemotherapy in patients with node-positive breast cancer: the American college of surgeons oncology group (ACOSOG) Z1071 clinical trial","author":"Boughey","year":"2013","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.ejso.2025.109689_bib36","article-title":"Assessment of sentinel lymph node biopsy after neoadjuvant chemotherapy for breast cancer in two subgroups: initially node negative and node positive converted to node negative \u2013 a systemic review and meta-analysis","volume":"24","author":"Shirzadi","year":"2019","journal-title":"J Res Med Sci"},{"issue":"3","key":"10.1016\/j.ejso.2025.109689_bib37","doi-asserted-by":"crossref","DOI":"10.1093\/bjs\/znae071","article-title":"Systematic review of targeted axillary dissection in node-positive breast cancer treated with neoadjuvant systemic therapy: variation in type of marker and timing of placement","volume":"111","author":"De Wild","year":"2024","journal-title":"Br J Surg"},{"issue":"15","key":"10.1016\/j.ejso.2025.109689_bib38","article-title":"Definition and impact of pathologic complete response on prognosis after neoadjuvant chemotherapy in various intrinsic breast cancer subtypes","volume":"30","author":"Von","year":"2012","journal-title":"J Clin Oncol"},{"issue":"8","key":"10.1016\/j.ejso.2025.109689_bib39","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2007.14.4147","article-title":"Response to neoadjuvant therapy and long-term survival in patients with triple-negative breast cancer","volume":"26","author":"Liedtke","year":"2008","journal-title":"J Clin Oncol"},{"issue":"16","key":"10.1016\/j.ejso.2025.109689_bib40","doi-asserted-by":"crossref","DOI":"10.21037\/atm-20-5172","article-title":"Association of higher axillary pathologic complete response rate with breast pathologic complete response after neoadjuvant chemotherapy","volume":"8","author":"Zhu","year":"2020","journal-title":"Ann Transl Med"},{"key":"10.1016\/j.ejso.2025.109689_bib41","doi-asserted-by":"crossref","DOI":"10.1016\/j.breast.2024.103671","article-title":"Axillary lymph node dissection in triple-negative or HER2-positive breast cancer patients with clinical N2 achieving pathological complete response after neoadjuvant therapy: is it necessary?","volume":"73","author":"Guo","year":"2024","journal-title":"Breast"},{"key":"10.1016\/j.ejso.2025.109689_bib42","doi-asserted-by":"crossref","DOI":"10.7759\/cureus.14610","article-title":"Targeted axillary dissection in node-positive breast cancer: a retrospective study and cost analysis","author":"Beniey","year":"2021","journal-title":"Cureus"},{"issue":"6","key":"10.1016\/j.ejso.2025.109689_bib43","doi-asserted-by":"crossref","DOI":"10.1016\/j.bulcan.2023.03.009","article-title":"Axillary pathologic response after neoadjuvant chemotherapy and surgery according to breast cancers subtypes and survival impact","volume":"110","author":"Jankowski","year":"2023","journal-title":"Bull Cancer"},{"issue":"3","key":"10.1016\/j.ejso.2025.109689_bib44","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14030521","article-title":"Pathological response in the breast and axillary lymph nodes after neoadjuvant systemic treatment in patients with initially node-positive breast cancer correlates with disease free survival: an exploratory analysis of the GeparOcto trial","volume":"14","author":"Gerber","year":"2022","journal-title":"Cancers"},{"issue":"2","key":"10.1016\/j.ejso.2025.109689_bib48","doi-asserted-by":"crossref","DOI":"10.1245\/s10434-020-08928-2","article-title":"Omission of axillary lymph node dissection is associated with inferior survival in breast cancer patients with residual N1 nodal disease following neoadjuvant chemotherapy","volume":"28","author":"Almahariq","year":"2021","journal-title":"Ann Surg Oncol"}],"container-title":["European Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0748798325001179?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0748798325001179?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,21]],"date-time":"2025-06-21T10:45:02Z","timestamp":1750502702000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0748798325001179"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":62,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["S0748798325001179"],"URL":"https:\/\/doi.org\/10.1016\/j.ejso.2025.109689","relation":{},"ISSN":["0748-7983"],"issn-type":[{"value":"0748-7983","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The efficacy and oncological safety of minimally invasive axillary procedures in patients with node-positive breast cancer receiving neoadjuvant chemotherapy: A network meta-regression and trial sequential analysis","name":"articletitle","label":"Article Title"},{"value":"European Journal of Surgical Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejso.2025.109689","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Crown Copyright \u00a9 2025 Published by Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"109689"}}